XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (650,033,000) $ (1,026,723,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 218,968,000 207,880,000
Non-cash reduction to the right-of-use asset 21,815,000 38,669,000
Net amortization of investment premium and discount 4,403,000 27,900,000
Impairment of long-lived assets due to office closures 34,278,000 97,722,000
Stock-based compensation including restructuring 509,367,000 606,260,000
Amortization of deferred commissions 54,428,000 41,322,000
Unrealized loss on equity securities 9,750,000 0
Allowance for doubtful accounts 41,454,000 21,786,000
Value of shares of Class A common stock issued and donated to charity 3,985,000 8,516,000
Share of losses from equity method investment 93,838,000 13,376,000
Loss on net assets divested 32,277,000 0
Impairment of strategic investments 46,154,000 0
Other adjustments 11,822,000 3,166,000
Changes in operating assets and liabilities:    
Accounts receivable (69,116,000) (121,353,000)
Prepaid expenses and other current assets (56,506,000) (81,071,000)
Other long-term assets (15,367,000) (111,662,000)
Accounts payable (2,578,000) 11,585,000
Accrued expenses and other current liabilities (59,677,000) 122,408,000
Deferred revenue and customer deposits 6,827,000 (6,206,000)
Operating lease liabilities (41,446,000) (42,158,000)
Other long-term liabilities (2,436,000) (7,330,000)
Net cash provided by (used in) operating activities 192,207,000 (195,913,000)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisitions, net of cash acquired and payments related to prior period acquisitions (5,770,000) (32,853,000)
Divestitures, net of cash divested 38,194,000 0
Purchases of marketable securities and other investments (1,391,975,000) (1,650,759,000)
Proceeds from sales and maturities of marketable securities 1,764,841,000 1,065,998,000
Capitalized software development costs (30,526,000) (35,905,000)
Purchases of long-lived and intangible assets (9,019,000) (28,634,000)
Net cash provided by (used in) investing activities 365,745,000 (682,153,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments of costs related to public offerings 0 (35,000)
Principal payments on debt and finance leases (13,763,000) (9,383,000)
Value of equity awards withheld for tax liabilities (2,536,000) (1,080,000)
Repurchases of shares of Class A common stock and related costs (548,871,000) 0
Proceeds from exercises of stock options and shares of Class A common stock issued under ESPP 28,949,000 43,750,000
Net cash (used in) provided by financing activities (536,221,000) 33,252,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash 108,000 146,000
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 21,839,000 (844,668,000)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period 656,078,000 1,481,831,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH —End of period 677,917,000 637,163,000
Cash paid for income taxes, net 22,916,000 5,481,000
Cash paid for interest 38,216,000 37,500,000
RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONDENSED CONSOLIDATED BALANCE SHEETS    
Cash and cash equivalents 677,917,000 632,794,000
Restricted cash in other current assets 0 4,357,000
Restricted cash in other long-term assets 0 12,000
Total cash, cash equivalents and restricted cash $ 677,917,000 $ 637,163,000